Transcatheter Mitral Valve Replacement for Mitral Valve-in-Valve, Valve-in-Ring, and Valve-in-MAC Using Balloon-Expandable Transcatheter Heart Valves
- PMID: 33888232
- DOI: 10.1016/j.jcin.2021.02.034
Transcatheter Mitral Valve Replacement for Mitral Valve-in-Valve, Valve-in-Ring, and Valve-in-MAC Using Balloon-Expandable Transcatheter Heart Valves
Keywords: TMVR; mitral valve; valve-in-MAC (ViMAC); valve-in-ring (ViR); valve-in-valve (ViV).
Conflict of interest statement
Funding Support and Author Disclosures Dr. Windecker has received research and educational grants to the institution from Abbott, Amgen, Bristol Myers Squibb, Bayer, Boston Scientific, Biotronik, Cardinal Health, Cardiovalve, CSL Behring, Daiichi-Sankyo, Edwards Lifesciences, Johnson & Johnson, Medtronic, Querbet, Polares, Sanofi, Terumo, and Sinomed; serves as an unpaid advisory board member and/or unpaid member of the steering or executive committees of trials funded by Abbott, Abiomed, Amgen, AstraZeneca, Bristol Myers Squibb, Boston Scientific, Biotronik, Cardiovalve, Edwards Lifesciences, MedAlliance, Medtronic, Novartis, Polares, Sinomed, V-Wave, and Xeltis but has not received personal payments from pharmaceutical companies or device manufacturers; is a member of the steering or executive committees of several investigated-initiated trials that receive funding from industry, without impact on his personal remuneration; and is an unpaid member of the Pfizer Research Award selection committee in Switzerland. Dr. Praz has received travel expenses from Abbott Vascular, Edwards Lifesciences, and Polares Medical. Dr. Reineke has a consultancy agreement with Abbott; has received proctoring fees from Abbott; and has received travel expenses from Abbott. Dr. Sticchi has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
Prospective Study of TMVR Using Balloon-Expandable Aortic Transcatheter Valves in MAC: MITRAL Trial 1-Year Outcomes.JACC Cardiovasc Interv. 2021 Apr 26;14(8):830-845. doi: 10.1016/j.jcin.2021.01.052. JACC Cardiovasc Interv. 2021. PMID: 33888229
-
Prospective Evaluation of TMVR for Failed Surgical Annuloplasty Rings: MITRAL Trial Valve-in-Ring Arm 1-Year Outcomes.JACC Cardiovasc Interv. 2021 Apr 26;14(8):846-858. doi: 10.1016/j.jcin.2021.01.051. JACC Cardiovasc Interv. 2021. PMID: 33888230
-
Prospective Evaluation of Transseptal TMVR for Failed Surgical Bioprostheses: MITRAL Trial Valve-in-Valve Arm 1-Year Outcomes.JACC Cardiovasc Interv. 2021 Apr 26;14(8):859-872. doi: 10.1016/j.jcin.2021.02.027. JACC Cardiovasc Interv. 2021. PMID: 33888231
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
